Stock PCVX VAXCYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Market Closed - Nasdaq
Other stock markets
 21:00:00 30/04/2024 BST 		5-day change 1st Jan Change
60.55 USD -0.79% Intraday chart for Vaxcyte, Inc. -0.54% -3.58%
04-25 Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing MT
04-22 Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing MT

Evolution of the average Target Price on Vaxcyte, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2ab9cf17ed75a9194a56f9ba59.-Wd8DiCEcja8ZS8jN_twVvUd_uPJtcDjbD1waNQKIds.zz0RaGmwLWTUNHlsRs0RboFElLb_wKqSWktDKa5ZZp6QXjZZeOoCD9QzFw~889ff8a204c0d2a2e94b56562ebe7aa1

Analyst Recommendations on Vaxcyte, Inc.

Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing MT
Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing MT
Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating MT
Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating MT
Mizuho Initiates Vaxcyte With Buy Rating, Price Target is $69 MT
TD Cowen Starts Vaxcyte at Outperform MT
BofA Securities Adjusts Price Target on Vaxcyte to $68 From $63, Keeps Buy Rating MT
Guggenheim Adjusts Price Target on Vaxcyte to $65 From $66, Maintains Buy Rating MT
Needham Adjusts Price Target on Vaxcyte to $58 From $52, Maintains Buy Rating MT
SVB Securities Initiates Vaxcyte With Outperform Rating, Sets Price Target at $60 MT
Guggenheim Initiates Vaxcyte at Buy With $66 Price Target MT
BTIG Starts Vaxcyte at Buy With $69 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
60.55 USD
Average target price
103.3 USD
Spread / Average Target
+70.58%
High Price Target
113 USD
Spread / Highest target
+86.62%
Low Price Target
95 USD
Spread / Lowest Target
+56.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vaxcyte, Inc.

Mizuho Securities
Needham & Co.
TD Cowen
BofA Securities
Guggenheim
SVB Securities LLC
BTIG

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PCVX Stock
  4. Consensus Vaxcyte, Inc.